Introduction 7.5032105
: 2.7003784
Ċ 1.1506985
Indian 15.676973
apolis 4.962321
- 4.7489467
based 0.38001278
Ġpharmaceutical 3.4133615
Ġgiant 1.0711858
, 2.697014
ĠEli 0.01742068
ĠLilly 0.02911458
Ġ& 1.8292125
ĠCo 0.520335
, 2.2505865
Ġis 1.5673552
Ġset 4.62791
Ġto 0.020065147
Ġannounce 4.0331135
Ġits 2.5263116
Ġthird 2.840555
- 1.6485549
quarter 0.016043682
Ġearnings 0.6999295
, 4.585453
Ġand 1.3763456
Ġindustry 5.922533
Ġexperts 2.2774432
Ġanticipate 3.327088
Ġa 1.6989528
Ġpositive 3.2935176
Ġtrajectory 7.0895824
Ġfor 0.8362879
Ġthe 0.14684759
Ġcompany 0.31125605
. 0.7853655
ĠExpect 7.403429
ations 0.02517033
Ġare 0.67008466
Ġhigh 0.78385234
Ġfor 1.2847602
Ġincreased 5.9076557
Ġprofits 2.871696
, 1.6919837
Ġdriven 2.934983
Ġby 0.3294683
Ġrobust 5.0423145
Ġsales 0.8153418
Ġof 0.39186183
Ġkey 3.3490355
Ġdrugs 0.8676812
Ġamid 9.312682
Ġthe 2.5326216
Ġongoing 3.2144063
ĠCO 14.342728
VID 8.389543
- 11.810147
19 8.807196
Ġpand 8.174918
emic 0.0007742779
. 0.54832035
ĠHowever 3.5036302
, 0.017896062
Ġanalysts 3.2617872
Ġare 1.3677726
Ġvoicing 6.9508715
Ġconcerns 0.68758994
Ġover 0.95777345
Ġpotential 4.66989
Ġprofit 5.653627
Ġmargin 2.9513304
Ġchallenges 5.2667665
Ġfaced 5.639657
Ġby 0.03656008
Ġthe 0.7158025
Ġcompany 0.21799436
. 1.4938157
ĠThis 3.8826423
Ġarticle 2.2960765
Ġdel 5.7555876
ves 0.0006075088
Ġinto 0.25331894
Ġthe 0.45770067
Ġfactors 3.2671013
Ġcontributing 4.3107095
Ġto 0.04470388
Ġelevated 7.9008846
Ġprofits 3.6040852
, 1.6272914
Ġwhile 2.8213391
Ġexploring 3.3303
Ġthe 0.7077153
Ġunderlying 3.8317087
Ġconcerns 2.9375644
Ġsurrounding 3.013393
ĠEli 1.7369163
ĠLilly 0.011637034
Ġ& 1.6710068
ĠCo 0.033080067
's 0.7638559
Ġprofit 2.6224496
Ġmargins 0.76538724
. 0.12673193
Ċ 0.33142328
R 5.650622
ising 0.22332667
ĠProf 1.1626117
its 0.009695308
ĠAmid 3.613579
ĠPand 4.0150576
emic 0.014739514
: 0.9993849
Ċ 0.13081689
E 1.3747462
li 0.003875694
ĠLilly 0.008129193
Ġ& 0.19395189
ĠCo 0.015953137
's 1.3003912
Ġsteady 8.578912
Ġsuccess 5.2439733
Ġcan 3.6912088
Ġbe 0.103806235
Ġattributed 0.24205408
Ġto 0.05790659
Ġa 2.0740001
Ġrange 3.1180139
Ġof 0.0024662192
Ġfactors 0.2149598
, 0.69421834
Ġincluding 0.6692784
Ġits 2.8280392
Ġstrategic 4.9340916
Ġfocus 1.6870581
Ġon 0.063261
Ġinnovative 3.362236
Ġmedicines 3.2301347
Ġand 1.3404058
Ġstrong 3.0898294
Ġproduct 2.8907824
Ġpipeline 1.1418307
. 0.48854366
ĠDuring 4.681045
Ġthe 0.33160788
Ġthird 1.530869
Ġquarter 0.17285095
, 0.39759058
Ġthe 0.49382022
Ġcompany 0.09332244
Ġwitnessed 3.1912172
Ġrobust 1.6739131
Ġsales 0.5787717
Ġof 0.38288012
Ġits 1.6960162
Ġblockbuster 3.021788
Ġdrugs 1.2198658
, 0.45874155
Ġsuch 2.1869493
Ġas 0.0018361505
ĠTr 1.0210636
ul 0.004856476
icity 0.024636194
, 0.598058
ĠT 1.3282249
alt 9.663671e-05
z 0.001224205
, 0.27066255
Ġand 1.2713176
ĠJ 1.5981368
ard 0.005772092
iance 0.0039477986
, 0.89341205
Ġall 3.342989
Ġof 0.1203195
Ġwhich 0.0027496652
Ġcontribute 3.917306
Ġsignificantly 1.4557025
Ġto 0.10223871
Ġits 1.1289614
Ġbottom 2.1896737
Ġline 0.43831262
. 0.07068215
ĠThe 2.622251
Ġcontinued 5.7680616
Ġdemand 3.2299135
Ġfor 0.050065026
Ġthese 1.0572646
Ġmedications 4.2952933
, 1.9841809
Ġcoupled 1.7421808
Ġwith 0.0034669137
Ġsuccessful 5.5223184
Ġmarketing 2.7640538
Ġstrategies 1.7491655
Ġand 2.4394028
Ġenhanced 5.1428547
Ġpatient 2.4340444
Ġaccess 1.6770619
, 0.77505517
Ġis 1.8747474
Ġanticipated 3.9453976
Ġto 0.0055751163
Ġdrive 1.1449505
Ġsubstantial 5.4408107
Ġrevenue 2.1146662
Ġgrowth 0.5277569
. 1.9365023
Ċ 1.2241141
Additionally 4.7642007
, 0.0016649051
ĠEli 1.8343846
ĠLilly 0.007317951
's 2.4102383
Ġrecent 3.0284796
Ġbreakthrough 5.9060497
Ġin 0.70898974
Ġthe 1.0200698
Ġdevelopment 1.292846
Ġof 0.030265898
ĠCO 5.0027776
VID 0.0024699243
- 0.0639162
19 0.0072989166
Ġtreatments 9.107301
Ġhas 1.8420342
Ġfurther 2.8926597
Ġbolstered 1.2963821
Ġits 0.95993775
Ġportfolio 5.382108
. 1.1947951
ĠThe 0.98415065
Ġpharmaceutical 5.9086127
Ġcompany 2.2352545
's 2.285692
Ġmon 6.1442823
oc 0.009078116
lon 0.0003342722
al 0.00032359784
Ġantibody 0.18165024
Ġtherapy 3.81605
, 0.7773624
Ġb 6.696929
am 11.556128
lan 17.117397
iv 10.713563
im 6.4674144
ab 0.08935614
, 0.18814792
Ġreceived 3.5935037
ĠEmergency 5.5481367
ĠUse 0.11704531
ĠAuthorization 0.4056022
Ġ( 0.924734
EU 0.017694077
A 0.00138565
) 0.06182121
Ġfrom 0.69463354
Ġthe 0.039243773
ĠUS 1.5295169
ĠFood 0.24605818
Ġand 0.0998755
ĠDrug 0.008741166
ĠAdministration 0.008677795
Ġ( 0.13510355
F 0.09530617
DA 0.00012167429
). 2.5627606
ĠThis 1.4095757
Ġauthorization 3.2128844
Ġenables 2.6933424
ĠEli 2.9590924
ĠLilly 0.004927034
Ġto 0.33402023
Ġsupply 2.681076
Ġits 1.6789324
Ġpotentially 5.563588
Ġlife 0.1394707
- 0.009601906
saving 0.0038904152
Ġtreatment 2.005195
Ġto 0.3303689
ĠCO 6.950867
VID 0.003579845
- 0.03984834
19 0.021438632
Ġpatients 0.34823507
, 1.6640309
Ġpotentially 6.7452974
Ġleading 3.9945858
Ġto 0.0074706483
Ġsubstantial 3.489624
Ġsales 2.4987369
Ġand 2.5770802
Ġfinancial 6.7963634
Ġgains 0.6953634
. 0.38623518
Ċ 0.606203
Con 6.551209
cern 0.032071736
s 0.024186792
ĠOver 0.7333293
ĠProfit 0.39850974
ĠMarg 0.0056065265
ins 0.2561351
: 0.13592143
Ċ 0.035712395
While 2.446168
ĠEli 1.2582139
ĠLilly 0.003707447
Ġ& 0.53069973
ĠCo 0.0068740966
's 0.7974134
Ġrising 4.7867265
Ġprofits 0.7495073
Ġdemonstrate 4.7799325
Ġits 1.032588
Ġstrong 2.7495415
Ġperformance 1.692127
, 0.5581615
Ġconcerns 2.4818306
Ġpersist 3.3694315
Ġover 0.6919294
Ġprofit 3.6236784
Ġmargins 0.34719992
. 0.47195885
ĠThe 1.3513716
Ġescalating 8.039118
Ġcosts 1.2212119
Ġof 0.30431813
Ġresearch 1.678133
Ġand 0.07645303
Ġdevelopment 0.021233616
, 1.4595883
Ġcoupled 0.45646214
Ġwith 0.0022504772
Ġinvestments 6.5113187
Ġin 0.27450275
Ġexpanding 5.4849677
Ġits 1.3227915
Ġmanufacturing 2.5493596
Ġcapabilities 1.9376314
, 0.2379843
Ġhave 1.7423266
Ġsqueezed 5.9091654
Ġmargins 3.022147
Ġfor 2.7543464
Ġthe 0.2030913
Ġcompany 0.5343433
. 0.16736312
ĠAdditionally 2.503921
, 0.0006793165
Ġincreased 3.8658206
Ġcompetition 0.59967625
Ġwithin 3.3732271
Ġthe 0.080326214
Ġpharmaceutical 0.76683784
Ġindustry 0.3601668
, 2.043233
Ġcombined 4.857207
Ġwith 0.00084407313
Ġthe 1.7940549
Ġimpending 4.3742266
Ġexpiration 1.9235904
Ġof 0.008176967
Ġpatents 1.1358227
Ġfor 0.6114847
Ġsome 1.604755
Ġof 0.17186546
ĠEli 2.2992682
ĠLilly 0.009872149
's 0.15641972
Ġkey 0.8413367
Ġdrugs 0.5325693
, 0.065456785
Ġposes 4.025931
Ġpotential 4.01889
Ġpricing 6.0770154
Ġchallenges 0.8565382
. 0.99874353
Ċ 0.832962
Moreover 3.6804297
, 0.0005937923
Ġongoing 5.5011353
Ġdiscussions 5.6880527
Ġon 2.5287352
Ġdrug 1.4974655
Ġpricing 0.20904666
Ġreforms 4.0948987
Ġwithin 4.053775
Ġthe 0.05844932
ĠUS 0.49992922
Ġhealthcare 2.4501238
Ġsystem 0.79325086
Ġcould 1.9566282
Ġsignificantly 3.9922686
Ġimpact 0.3626158
Ġthe 1.0265507
Ġoverall 5.7496552
Ġprofitability 0.9685567
Ġof 0.19568127
Ġpharmaceutical 2.4277258
Ġcompanies 0.16221379
Ġlike 3.3011782
ĠEli 0.0095321005
ĠLilly 0.0035882806
. 0.80846983
ĠPossible 7.7768373
Ġchanges 2.1670928
Ġto 0.6785479
Ġdrug 2.1302614
Ġpricing 0.22225611
Ġpolicies 1.9690841
Ġand 3.102025
Ġincreased 4.0833015
Ġpressure 2.3412232
Ġfor 2.9904978
Ġaffordable 4.5739164
Ġaccess 3.5600407
Ġto 0.168493
Ġmedications 1.7696674
Ġcould 0.5962227
Ġimpact 3.2098384
Ġthe 0.85883975
Ġcompany 0.7722702
's 0.05339856
Ġpricing 2.5635784
Ġpower 2.4048448
Ġand 1.5598059
Ġexert 9.038561
Ġdownward 0.48084998
Ġpressure 0.030046597
Ġon 0.010965971
Ġmargins 2.7799487
. 0.10572537
Ċ 0.34119043
Out 8.893591
look 0.019652499
Ġand 0.8738142
ĠStrategies 8.43406
: 0.18066496
Ċ 0.020529378
Despite 2.3774085
Ġthe 1.3031898
Ġconcerns 1.6053127
Ġsurrounding 1.1461326
Ġprofit 0.8562366
Ġmargins 0.03558676
, 0.1109991
ĠEli 0.4098059
ĠLilly 0.005089196
Ġ& 0.30172673
ĠCo 0.006870915
Ġremains 2.584541
Ġoptimistic 1.430659
Ġabout 0.46615103
Ġits 0.3965711
Ġfuture 1.0614117
Ġgrowth 1.9289478
Ġprospects 0.48347715
. 0.12180482
ĠThe 0.40110788
Ġpharmaceutical 2.5381384
Ġmanufacturer 4.5952945
Ġcontinues 2.9363487
Ġto 0.027961154
Ġadvance 5.40934
Ġits 0.41069028
Ġrobust 5.2490845
Ġresearch 3.4682703
Ġand 0.28186113
Ġdevelopment 0.03644083
Ġpipeline 0.67087376
, 0.45089993
Ġfocusing 3.1452842
Ġon 0.07549631
Ġinnovative 1.5863255
Ġtherapies 2.1032913
Ġfor 1.6534338
Ġvarious 3.193414
Ġdiseases 1.3788785
. 0.6955386
ĠMoreover 2.776511
, 0.0003993836
Ġthe 0.51919717
Ġcompany 0.1589105
Ġstrateg 10.512607
izes 0.043127555
Ġto 0.23965444
Ġexpand 1.2768927
Ġits 0.2662339
Ġglobal 2.1120853
Ġpresence 1.3514773
Ġthrough 2.0084069
Ġpartnerships 2.1542978
Ġand 0.57285917
Ġacquisitions 1.3670363
, 1.1496685
Ġaiming 3.7675848
Ġto 0.02617014
Ġdivers 4.1800227
ify 4.7399757e-05
Ġits 0.20521258
Ġrevenue 2.0159674
Ġstreams 0.78810364
Ġand 0.6460792
Ġreduce 3.8730912
Ġdependency 4.1207604
Ġon 0.012539929
Ġindividual 3.6528895
Ġblockbuster 5.966218
Ġdrugs 0.14933698
. 0.041784436
Ċ 0.57022244
E 2.1093724
li 0.005287814
ĠLilly 0.008109482
Ġ& 0.5718233
ĠCo 0.013120852
Ġis 2.0403354
Ġalso 1.9918896
Ġengaging 5.899966
Ġin 0.26657417
Ġongoing 3.1785002
Ġefforts 2.5472112
Ġto 0.039645553
Ġmanage 5.404321
Ġcosts 1.7251228
Ġeffectively 5.1646104
Ġand 1.1429945
Ġoptimize 4.1003375
Ġits 0.85408777
Ġmanufacturing 1.6657665
Ġprocesses 2.1758714
. 0.40252095
ĠBy 3.3805914
Ġenhancing 3.8968773
Ġoperational 2.048127
Ġeffic 0.70384043
iencies 0.0006552833
Ġand 0.7154945
Ġexploring 4.548508
Ġtechnological 4.7218204
Ġadvancements 1.2749171
, 0.16201808
Ġthe 0.06965296
Ġcompany 0.1265078
Ġaims 0.9540983
Ġto 0.0026696979
Ġcounter 5.614237
Ġthe 1.3886998
Ġchallenges 2.167483
Ġposed 1.3688939
Ġby 0.018922824
Ġrising 1.2325732
Ġcosts 0.7972298
Ġand 0.59646744
Ġpotential 4.2189503
Ġpricing 0.7720002
Ġpressures 0.515028
. 0.14076859
Ċ 0.59403884
Conclusion 4.4258337
: 0.02740604
Ċ 0.040388998
E 0.7822092
li 0.0013153987
ĠLilly 0.008208277
Ġ& 0.0858766
ĠCo 0.005660473
's 0.85710436
Ġthird 1.9395609
- 0.14250968
quarter 0.0010863014
Ġearnings 0.5692502
Ġare 0.86590624
Ġexpected 1.2509632
Ġto 0.0043549784
Ġshowcase 3.598336
Ġa 2.4798102
Ġstrong 1.7601213
Ġupward 4.5979776
Ġtrajectory 0.4256824
Ġin 2.451712
Ġprofits 1.8346143
, 0.74055755
Ġprimarily 4.2518067
Ġfueled 4.887327
Ġby 0.0015773836
Ġrobust 1.3097154
Ġsales 0.15837327
Ġof 0.11866107
Ġtheir 7.2797217
Ġblockbuster 1.9880499
Ġdrugs 0.16030873
Ġand 1.6379142
Ġbreakthrough 3.3463504
s 2.6348696
Ġin 0.06501053
ĠCO 1.2922112
VID 0.0028633527
- 0.0031287333
19 0.0010371358
Ġtreatments 0.7157933
. 0.010187265
ĠHowever 0.70633024
, 0.0005752417
Ġconcerns 1.5128074
Ġlinger 3.5552666
Ġover 0.21618234
Ġtheir 6.351341
Ġprofit 0.79455674
Ġmargins 0.06747414
, 0.35068628
Ġstemming 5.0345407
Ġfrom 0.10108354
Ġrising 1.8180856
Ġcosts 0.50244284
Ġof 1.1259823
Ġresearch 0.4581302
Ġand 0.02774131
Ġdevelopment 0.009081186
, 0.6955065
Ġpotential 4.6434536
Ġpricing 0.15409894
Ġpressures 0.37871373
, 0.23468918
Ġand 0.044230722
Ġdrug 5.163444
Ġpricing 0.17185599
Ġreforms 0.07818799
. 0.4936497
ĠThe 2.026551
Ġcompany 0.4504381
's 1.6053739
Ġfuture 2.619952
Ġsuccess 1.8001603
Ġhinges 2.8491256
Ġon 0.2377784
Ġits 0.30879325
Ġability 0.24813649
Ġto 0.001449099
Ġeffectively 1.8406863
Ġmanage 0.5548483
Ġthese 1.003284
Ġchallenges 0.91937494
, 1.2518612
Ġwhile 0.91224134
Ġcontinuing 2.0030544
Ġto 0.094593994
Ġinnovate 2.6208353
Ġand 0.3704941
Ġexpand 1.1367358
Ġits 0.2747978
Ġproduct 0.5481644
Ġportfolio 0.5054281
. 0.18806086
